Bulls eventually took over Nifty Pharma with the index climbing at least 1% led by a broad-based buy. The index took a positive turn after being under pressure for the past few days. Traders are bullish on the index as India's vaccination campaign accelerates.
At around 1:48 p.m., the Nifty Pharma Index traded at 14,057.90 to 92.50 points or 0.66%. The index has touched intraday highs and lows of 14,118.80 and 13,969.75.
Torrent Pharma was the winner with more than 2.5%, followed by Cipla and Divis Lab, with an increase of more than 1% each.
Dr Reddy's Lab and Lupine advanced 0.7% and 0.6% respectively. Sun Pharma and Alkem Lab were unchanged.
Downward, Cadila Healthcare it fell 0.6% and emerged as the main bear followed by Biocon with a marginal disadvantage.
The Ministry of Health and Family Welfare said today that India has administered more than 88.13 lakh doses in the last 24 hours as part of its nationwide vaccination campaign. This is the highest vaccination ever achieved in a single day since the start of our vaccination campaign. Along with this, India's COVID-19 vaccination coverage achieved a milestone of 55 Cr yesterday. Together, around 55,47,30,609 doses of vaccine have been administered through 62,12,108 sessions, according to the interim report. until 7 am today.
The ministry said that the new phase of universalization of COVID-19 vaccination has started from June 21, 2021. The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.
India's recovery rate is 97.51%, the highest since March 2020.
